drugset / Trial / NCT00404820
Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study was to examine the effect of zoledronic acid and alendronate on bone metabolism as measured by biomarkers in postmenopausal women with osteoporosis.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alendronic Acid | Small molecule | 70 mg | Oral |
| Subject | Zoledronic acid | Other / unclassified | 5 mg | Intravenous |
| Background | Calcium carbonate | Other / unclassified | 1200 mg | Oral |
| Background | Vitamin D | Other / unclassified | 800 iu | Oral |